Needham’s Michael Matson warns that there’s too much uncertainty surrounding MDXG for him to stay bullish.
Did an iceberg just wallop into MiMedx Group Inc’s (NASDAQ:MDXG) stock? The medical-device maker’s shares are plunging at breakneck speed of over 35%, on …
In a research note issued today, Canaccord analyst William Plovanic maintained a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target of …
In a research report released today, Needham analyst Michael Matson reiterated a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target …
